Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an individual randomized controlled trial (RCT) is underpowered to determine whether SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Uaprasert, Noppacharn, Panrong, Krissana, Rojnuckarin, Ponlapat, Chiasakul, Thita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590131/
https://www.ncbi.nlm.nih.gov/pubmed/34774069
http://dx.doi.org/10.1186/s12959-021-00340-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590131/
https://www.ncbi.nlm.nih.gov/pubmed/34774069
http://dx.doi.org/10.1186/s12959-021-00340-4

Ejemplares similares